ON APRIL 9, 2024, THE SENATE ADOPTED AMENDMENT #1 AND PASSED SENATE BILL 1930, AS AMENDED.
AMENDMENT #1 rewrites the bill to, instead, require the department of health to conduct a review and issue a report to the general assembly on variants of the apolipoprotein L1 (APOL1) gene associated with increased risk of end-stage renal disease. The report must include (i) recommendations on how to increase awareness for APOL1, including screening and genetic testing; (ii) an analysis of strategies and funding to increase screening and genetic testing for APOL1 in this state; and (iii) other relevant information or issues identified by the department.

Statutes affected:
Introduced: 68-5-504(b)(1), 68-5-504